✦ LIBER ✦
Budget Impact of the Introduction of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir, the First Integrase Inhibitor-Based Single Tablet Antiretroviral Regimen for HIV Treatment, to Third Party Payers in the United States
✍ Scribed by Brogan, A.; Talbird, S.E.; Thompson, J.R.; Kim, Y.A.; Olson, J.; Peterson, J.; Piontkowsky, D.; Pietrandoni, G.
- Book ID
- 122243545
- Publisher
- John Wiley and Sons
- Year
- 2013
- Tongue
- English
- Weight
- 82 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.